-
1
-
-
34347394385
-
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
-
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
-
(2007)
Ann Intern Med
, vol.146
, pp. 857-867
-
-
Hart, R.G.1
Pearce, L.A.2
Aguilar, M.I.3
-
2
-
-
0037145826
-
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
-
van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. J Am Med Assoc 2002; 288: 2441-2448.
-
(2002)
J Am Med Assoc
, vol.288
, pp. 2441-2448
-
-
van Walraven, C.1
Hart, R.G.2
Singer, D.E.3
-
3
-
-
84888400659
-
Vitamin K antagonists in heart disease: Current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
-
De Caterina R, Husted S, Wallentin L, et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 110: 1087-1107.
-
(2013)
Thromb Haemost
, vol.110
, pp. 1087-1107
-
-
De Caterina, R.1
Husted, S.2
Wallentin, L.3
-
4
-
-
79952301326
-
Apixaban in patients with atrial fibrillation
-
Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817.
-
(2011)
N Engl J Med
, vol.364
, pp. 806-817
-
-
Connolly, S.J.1
Eikelboom, J.2
Joyner, C.3
-
5
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
-
6
-
-
84888362796
-
Edoxaban versus warfarin in patients with atrial fibrillation
-
Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-2104.
-
(2013)
N Engl J Med
, vol.369
, pp. 2093-2104
-
-
Giugliano, R.P.1
Ruff, C.T.2
Braunwald, E.3
-
7
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
8
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
9
-
-
84896117299
-
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials
-
Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955-962.
-
(2014)
Lancet
, vol.383
, pp. 955-962
-
-
Ruff, C.T.1
Giugliano, R.P.2
Braunwald, E.3
-
10
-
-
84878535107
-
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation
-
Wallentin L, Lopes RD, Hanna M, et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation 2013; 127: 2166-2176.
-
(2013)
Circulation
, vol.127
, pp. 2166-2176
-
-
Wallentin, L.1
Lopes, R.D.2
Hanna, M.3
-
11
-
-
84888415701
-
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
-
Gallego P, Roldan V, Marin F, et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013; 110: 1189-1198.
-
(2013)
Thromb Haemost
, vol.110
, pp. 1189-1198
-
-
Gallego, P.1
Roldan, V.2
Marin, F.3
-
12
-
-
70349657518
-
Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: A systematic review
-
Wan Y, Heneghan C, Perera R, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circulation Cardiovasc Qual Outcom 2008; 1: 84-91.
-
(2008)
Circulation Cardiovasc Qual Outcom
, vol.1
, pp. 84-91
-
-
Wan, Y.1
Heneghan, C.2
Perera, R.3
-
13
-
-
84889886957
-
Effect of warfarin on intracranial haemorrhage incidence and fatal outcomes
-
Witt DM, Delate T, Hylek EM, et al. Effect of warfarin on intracranial haemorrhage incidence and fatal outcomes. Thrombosis Res 2013; 132: 770-775.
-
(2013)
Thrombosis Res
, vol.132
, pp. 770-775
-
-
Witt, D.M.1
Delate, T.2
Hylek, E.M.3
-
14
-
-
84904597072
-
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: Results from the ROCKET AF trial
-
Piccini JP, Hellkamp AS, Lokhnygina Y, et al. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. J Am Heart Assoc 2014; 3: e000521.
-
(2014)
J Am Heart Assoc
, vol.3
-
-
Piccini, J.P.1
Hellkamp, A.S.2
Lokhnygina, Y.3
-
15
-
-
79955084921
-
International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy
-
Gulati G, Hevelow M, George M, et al. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med 2011; 135: 490-494.
-
(2011)
Arch Pathol Lab Med
, vol.135
, pp. 490-494
-
-
Gulati, G.1
Hevelow, M.2
George, M.3
-
16
-
-
84876010146
-
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: Could this explain their differential effects on intracranial haemorrhage and myocardial infarction?
-
Dale B, Eikelboom JW, Weitz JI, et al. Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial haemorrhage and myocardial infarction? J Thrombosis Thrombol 2013; 35: 295-301.
-
(2013)
J Thrombosis Thrombol
, vol.35
, pp. 295-301
-
-
Dale, B.1
Eikelboom, J.W.2
Weitz, J.I.3
-
17
-
-
29244463365
-
Astrocyte-endothelial interactions at the blood-brain barrier
-
Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Rev Neurosci 2006; 7: 41-53.
-
(2006)
Nature Rev Neurosci
, vol.7
, pp. 41-53
-
-
Abbott, N.J.1
Ronnback, L.2
Hansson, E.3
-
18
-
-
84888292079
-
Brain regulation of thrombosis and haemostasis: From theory to practice
-
Fisher MJ. Brain regulation of thrombosis and haemostasis: from theory to practice. Stroke 2013; 44: 3275-3285.
-
(2013)
Stroke
, vol.44
, pp. 3275-3285
-
-
Fisher, M.J.1
-
19
-
-
77957988717
-
Prevalence and risk factors of cerebral microbleeds: An update of the Rotterdam scan study
-
Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010; 41 (10 Suppl): S103-S106.
-
(2010)
Stroke
, vol.41
, Issue.10
, pp. S103-S106
-
-
Poels, M.M.1
Vernooij, M.W.2
Ikram, M.A.3
-
20
-
-
60549083975
-
Cerebral microbleeds are a risk factor for warfarin-related intracerebral haemorrhage
-
Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral haemorrhage. Neurology 2009; 72: 171-176.
-
(2009)
Neurology
, vol.72
, pp. 171-176
-
-
Lee, S.H.1
Ryu, W.S.2
Roh, J.K.3
-
21
-
-
51649110437
-
Association between cerebral microbleeds on T2*-weighted MR images and recurrent haemorrhagic stroke in patients treated with warfarin following ischemic stroke
-
Ueno H, Naka H, Ohshita T, et al. Association between cerebral microbleeds on T2*-weighted MR images and recurrent haemorrhagic stroke in patients treated with warfarin following ischemic stroke. Am J Neuroradiol 2008; 29: 1483-1486.
-
(2008)
Am J Neuroradiol
, vol.29
, pp. 1483-1486
-
-
Ueno, H.1
Naka, H.2
Ohshita, T.3
-
22
-
-
58149357106
-
Experimental model of warfarin-associated intracerebral haemorrhage
-
Foerch C, Arai K, Jin G, et al. Experimental model of warfarin-associated intracerebral haemorrhage. Stroke 2008; 39: 3397-3404.
-
(2008)
Stroke
, vol.39
, pp. 3397-3404
-
-
Foerch, C.1
Arai, K.2
Jin, G.3
-
23
-
-
76749165687
-
Kinetics of hematoma expansion in murine warfarin-associated intracerebral haemorrhage
-
Illanes S, Zhou W, Heiland S, et al. Kinetics of hematoma expansion in murine warfarin-associated intracerebral haemorrhage. Brain Res 2010; 1320: 135-142.
-
(2010)
Brain Res
, vol.1320
, pp. 135-142
-
-
Illanes, S.1
Zhou, W.2
Heiland, S.3
-
24
-
-
80053978431
-
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral haemorrhage
-
Lauer A, Cianchetti FA, Van Cott EM, et al. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral haemorrhage. Circulation 2011; 124: 1654-1662.
-
(2011)
Circulation
, vol.124
, pp. 1654-1662
-
-
Lauer, A.1
Cianchetti, F.A.2
Van Cott, E.M.3
-
25
-
-
84875232430
-
Intracerebral haemorrhage associated with antithrombotic treatment: Translational insights from experimental studies
-
Lauer A, Pfeilschifter W, Schaffer CB, et al. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol 2013; 12: 394-405.
-
(2013)
Lancet Neurol
, vol.12
, pp. 394-405
-
-
Lauer, A.1
Pfeilschifter, W.2
Schaffer, C.B.3
-
26
-
-
84880276047
-
Novel oral anticoagulants in gastroenterology practice
-
Desai J, Granger CB, Weitz JI, et al. Novel oral anticoagulants in gastroenterology practice. Gastrointest Endoscopy 2013; 78: 227-239.
-
(2013)
Gastrointest Endoscopy
, vol.78
, pp. 227-239
-
-
Desai, J.1
Granger, C.B.2
Weitz, J.I.3
-
27
-
-
84869109465
-
Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans
-
Bathala MS, Masumoto H, Oguma T, et al. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. Drug Metabol Disp 2012; 40: 2250-2255.
-
(2012)
Drug Metabol Disp
, vol.40
, pp. 2250-2255
-
-
Bathala, M.S.1
Masumoto, H.2
Oguma, T.3
-
28
-
-
38749131205
-
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
-
Blech S, Ebner T, Ludwig-Schwellinger E, et al. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. Drug Metabol Disp 2008; 36: 386-399.
-
(2008)
Drug Metabol Disp
, vol.36
, pp. 386-399
-
-
Blech, S.1
Ebner, T.2
Ludwig-Schwellinger, E.3
-
29
-
-
58149458160
-
Apixaban metabolism and pharmacokinetics after oral administration to humans
-
Raghavan N, Frost CE, Yu Z, et al. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metabol Disp 2009; 37: 74-81.
-
(2009)
Drug Metabol Disp
, vol.37
, pp. 74-81
-
-
Raghavan, N.1
Frost, C.E.2
Yu, Z.3
-
30
-
-
66449099711
-
Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans
-
Weinz C, Schwarz T, Kubitza D, et al. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metabol Disp 2009; 37: 1056-1064.
-
(2009)
Drug Metabol Disp
, vol.37
, pp. 1056-1064
-
-
Weinz, C.1
Schwarz, T.2
Kubitza, D.3
-
31
-
-
79958126202
-
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
-
Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011; 123: 2363-2372.
-
(2011)
Circulation
, vol.123
, pp. 2363-2372
-
-
Eikelboom, J.W.1
Wallentin, L.2
Connolly, S.J.3
|